Prometheus Biosciences Selected Site — Glenview, Illinois

Prometheus Biosciences Selected Site is a clinical research site located in Glenview, Illinois, United States 60026.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Prometheus Biosciences Selected Site has participated in 1 clinical trials.

Therapeutic areas: Ulcerative Colitis.

Sponsors: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prometheus Biosciences Selected Site?

Prometheus Biosciences Selected Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prometheus Biosciences Selected Site conducted?

Prometheus Biosciences Selected Site has 1 clinical trials on record. Their work covers Ulcerative Colitis.

Is Prometheus Biosciences Selected Site accredited by Crixeo Health?

Prometheus Biosciences Selected Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Prometheus Biosciences Selected Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.